News
Neuralink shouldn’t solve Anxiety and Depression disorders
Neuralink aims to treat some of the most severe and damaging neurological diseases on Earth. In terms of Alzheimer’s, dementia, and epilepsy, a Neuralink device would be a great way to prevent these diseases from ruining everyday life for those who have been affected by them. With that being said, Neuralink needs not to treat anxiety and depression disorders, because those illnesses require human reaction and vulnerability to treat. Defeating anxiety and depression should be done without the help of a complete fix, and it is crucial not to look past the importance of humans being able to feel these two sensations.
This is something I feel very strongly about for several reasons.
Before I dive into those reasons, I want to explain why I feel qualified enough to take a stance that I think many supporters of Neuralink will disagree with.
I have dealt with clinical anxiety and severe depression for my entire life. I was clinically diagnosed in 2009 at the age of 14 with both of these disorders, and I would estimate that it took me around 11 and a half years of diligence on my part to begin living a normal life. My anxiety and depression disorders hindered me from doing a lot of things in my life: playing certain sports, moving away for college (on multiple occasions), keeping past jobs, committing to relationships, etc. It has affected me in the worst way for so many years, and I would never want anyone, even my worst enemy, to experience the things that I felt on a daily basis when I was under the control of these two diseases.
However, I don’t think that everyone should completely rid themselves of anxiety and depression. Why? Because they are two emotions, as humans, we need to have.
Anxiety, while painful and difficult to confront head-on, is necessary for some reasons. The first being the obvious, anxiety is an excellent way to sense when danger is near, and it is a crucial part of our fight or flight response. It can warn someone when there is an issue with what is going on near them and can be life-saving in certain circumstances.
Anxiety also is an opportunity to grow as a human being. Facing and confronting anxious thoughts is one of the best ways to test resilience and learn about what we are made of. Anxiety teaches us a lot about ourselves, and while frightening, facing it directly is one of the best ways to show that we can push through certain circumstances that we aren’t confident about.
This is a preview from our weekly newsletter. Each week I go ‘Beyond the News’ and handcraft a special edition that includes my thoughts on the biggest stories, why it matters, and how it could impact the future.
A big thanks to our long-time supporters and new subscribers! Thank you.
Depression, while more severe in my own experiences, also has its advantages. Without darkness, we wouldn’t know what light is. Without depression, we wouldn’t know about happiness. There are points where humans need to face adversity and challenging circumstances to feel the great things about life.
Now, the way I treated my anxiety and depression disorders was a clinically-focused approach. I regularly attended therapy sessions, took medication, and spoke to doctors as often as I could. While I wholeheartedly believe everyone should talk to a therapist at least three times a year, I disagree with taking medications. In my experience, they are a masking agent for anxiety and depression disorders, especially. They caused me more problems after I started taking them, and the side effects needed treatment on their own.
I believe the best way to treat disorders like anxiety and depression is solely up to the person who is dealing with them. When I started to make real progress with my issues, I began using Exposure Therapy to treat my problems. I did as many things as I could that scared me. This included long drives by myself, roller coasters, and doing more things independently. When I started doing these things, I had stopped taking medication, and my self-diligence started to solve the problems I was facing.
I am in no way condoning that medication is not a wrong way to initially treat these illnesses. However, I do not believe that the healthy dose of side effects that come as a result of taking these medications is helpful to anyone who is being treated for either disorder.
This is where my issue with Neuralink comes in.
I believe that Neuralink intends to completely remove these sensations from a person’s emotions, which I feel can be dangerous to the future. Taking away emotions from humans can be detrimental to the way people communicate with each other and respond to specific events. As hazardous and as stressful as dealing with any mental illness is, solving them requires a long and tiring fight. It is not easy, but anything in life that is worth doing rarely is.
I believe very strongly that removing emotions from humans is one of the most dangerous things that anyone could do. At what point will devices like Neuralink completely take over the human brain? When will emotions begin to disappear from people? Could it lead to a decreased amount of social interaction? How would that make us any different than robots?
It is dangerous, in my opinion, to remove core emotional responses from a human. Nobody wants to be depressed, and nobody wants to be anxious. But treating these diseases is done by finding out who we are as people. It requires us to go out of our comfort zones and grow, not put a chip in our heads or a pill in our throats that eliminates the possibility of feeling certain sensations.
There comes the point where our humanness needs to be preserved. The invention of Smartphones has taken away a lot of opportunities for face-to-face interaction, and there is plenty of evidence to suggest that anxiety and depression disorders are caused by these devices, especially through social media use.
I am interested to hear other points on this matter because I know some people have different experiences with anxiety and depression than me. One thing I’ve always loved is hearing other people’s stories about how their anxiety or depression changed their lives. It usually starts with a valley and turns into a peak. While this can differ from case to case, two people rarely have identical stories when talking about their experiences. They also, frequently, are different from one case to the next because of how we obtained anxiety or depression. Some get it through abuse, and some get it from other forms of trauma when their brain is developing.
Neuralink is yet another brilliant idea from Elon Musk. It will hopefully change the way certain neurological diseases are treated and can provide some insight into what causes these medical conditions. However, there has to be boundaries and taking emotions and psychological responses away, in my opinion, is not the right thing to do. To quote Dr. Martin Luther King Jr., “Darkness cannot drive out darkness; only light can do that.”
I use this newsletter to share my thoughts on what is going on in the Tesla world. If you want to talk to me directly, you can email me or reach me on Twitter. I don’t bite, be sure to reach out!
Tesla (NASDAQ: TSLA) is set to hold its Earnings Call for the first quarter of 2026 on Wednesday, and there are a lot of interesting things that are swirling around in terms of speculation from investors.
With the company’s executives, including CEO Elon Musk, answering a handful of questions that investors submit through the Say platform, fans want to know a lot of things about a lot of things.
These five questions come from Retail Investors, who are normal, everyday shareholders:
- When will we have the Optimus v3 reveal? When will Optimus production start, since we ended the Model S and Model X production earlier than mid-year? What’s the expected Optimus production rate exiting this year? What are the initial targeted skills?
- What milestones are you targeting for unsupervised FSD and Robotaxi expansion beyond Austin this year, and how will that drive recurring revenue?
- How will Hardware 3 cars reach Unsupervised Full Self-Driving?
- When do you expect Unsupervised Full Self-Driving to reach customer cars?
- When will Robotaxi expand past its current limited rollout?
Additionally, these are currently the three questions that are slated to be answered by Institutional Firms, which also answer a handful of questions during the call:
- Now that FSD has been approved in the Netherlands and is expected to launch across Europe this summer, can you discuss your Robotaxi strategy for the region?
- What enabled you to finish the AI5 tapeout early and were there any changes to the original vision? Last week, Elon said AI5 will go into Optimus and the Supercomputer, but one month ago said it would go into the Robotaxi. Has AI5 been dropped from the vehicle roadmap?
- Given the recent NHTSA incident filings, can you update us on the Robotaxi safety data? If safety validation remains the primary bottleneck, why not deploy thousands of vehicles to accelerate the removal of the safety driver?
The questions range through every current Tesla project, including FSD expansion and Optimus. However, many of the answers we will get will likely be repetitive answers we’ve heard in the past.
This is especially pertinent when the questions about when Unsupervised FSD will reach customer cars: we know Musk will say that it will happen this year. Is Tesla capable of that? Maybe. But a more transparent answer that is more revealing of a true timeline would be appreciated.
Hardware 3 owners are anxiously awaiting the arrival of FSD v14 Lite, which was promised to them last year for a release sometime this year.
The Earnings Call is set to take place on Wednesday at market close.
Elon Musk
Elon Musk reveals shocking Tesla Optimus patent detail
What looked promising on paper and in simulations failed to deliver the reliability required for a robot expected to handle delicate tasks like folding laundry, assembling electronics, or assisting in factories and homes.
Elon Musk revealed a shocking detail on the Tesla Optimus patent that was revealed last week. Despite it being made public for the first time, Musk said the company has already moved on from the design, an incredible truth about the development of new technology: things move fast.
Musk dropped a bombshell about the Tesla Optimus humanoid robot hand patent that was released last week. Musk, candidly replying to a post late at night on X, revealed that what is a new technology to many fans and insiders is actually old news to those developing the tech directly.
“We already changed the design,” Musk said. “This one didn’t actually work.”
We already changed the design. This one didn’t actually work.
— Elon Musk (@elonmusk) April 19, 2026
Patents, after all, are often viewed as blueprints for future products. Yet Musk revealed that the rolling contact mechanism—intended to provide smooth, low-friction articulation in the fingers—had already been scrapped after real-world testing exposed its shortcomings.
What looked promising on paper and in simulations failed to deliver the reliability required for a robot expected to handle delicate tasks like folding laundry, assembling electronics, or assisting in factories and homes.
The hand has been one of the biggest challenges for Tesla engineers since Optimus development started years ago. Musk has said that there is not enough recognition for how incredible and useful the human hand is, and designing one for a humanoid robot has been the biggest challenge of all.
Tesla is stumped on how to engineer this Optimus part, but they’re close
This moment underscores the persistent engineering hurdles in achieving reliable humanoid hand dexterity. Human fingers are marvels of evolution: 27 bones, intricate tendons, ligaments, and a network of sensors working in perfect harmony. Replicating that in metal and silicon is extraordinarily difficult.
Rolling contacts promised reduced wear and precise motion, but testing likely revealed issues with durability under repeated stress, grip stability on varied surfaces, or the micro-precision needed for fine motor skills.
These aren’t minor tweaks, but instead they represent fundamental challenges that have plagued robotics teams for decades. Even advanced competitors struggle here—hands remain the Achilles’ heel of most humanoids because the margin for error is razor-thin.
A fraction of a millimeter off, and a robot drops a glass or fails to button a shirt.
What makes Musk’s reply remarkable is how it signals Tesla’s direct communication style on prototype limitations. While many companies guard failures behind glossy marketing and vague timelines, Tesla openly shares setbacks.
Musk was forthcoming about the failure of this recent design. This transparency builds trust with investors, engineers, and fans. It shows Tesla treats Optimus development like true science: rapid iteration, rigorous testing, and zero tolerance for hype that doesn’t match reality.
The disclosure from Musk also highlights Tesla’s blistering pace of development. By the time the patents are published, which is often over a year after the initial filing, the technology has already evolved.
Optimus is far from a static product, and it’s a living project advancing weekly.
In the high-stakes race for general-purpose robots, Tesla’s approach stands out. Admitting a finger-joint design “didn’t actually work” isn’t a weakness—it’s confidence.
True innovation demands confronting failure head-on, and Musk just reminded the world that Optimus is being engineered that way. The next version of those hands is already in testing, and it will be better because Tesla isn’t afraid to say what didn’t work.
Elon Musk
Tesla is sending its humanoid Optimus robot to the Boston Marathon
Tesla’s Optimus robot is heading to the Boston Marathon finish line
Tesla’s Optimus humanoid robot will be stationed at the Tesla showroom at 888 Boylston Street in Boston, right along the final stretch of the Boston Marathon today, ready to cheer on runners and pose for photos with spectators.
According to a Tesla email shared by content creator Sawyer Merritt on X, Optimus will be at the Boston Boylston Street showroom on April 20, coinciding with Marathon Monday weekend. The Boston Marathon finishes on Boylston Street, and the surrounding area draws hundreds of thousands of spectators along with international broadcast coverage. Placing Optimus there puts it in front of a massive public audience at zero advertising cost.
Just got this email. @Tesla’s Optimus robot is coming to Boston.
“Join us from April 19 to 20, 2026, at Tesla Boston Boylston Street showroom to meet Optimus, our humanoid robot, for Marathon Monday. Optimus will be cheering with you on the sidelines and posing for photos.” pic.twitter.com/chxoooO2xV
— Sawyer Merritt (@SawyerMerritt) April 18, 2026
The Tesla showroom is at 888 Boylston Street, between Gloucester Street and Fairfield Street. The final mile of the marathon runs directly along Boylston Street, with runners passing the big stores before reaching the finish line at Copley Square.
Optimus was first announced at Tesla’s AI Day event on August 19, 2021, when Elon Musk presented a vision for a general-purpose robot designed to take on dangerous, repetitive, and unwanted tasks. In March 2026, Optimus appeared at the Appliance and Electronics World Expo in Shanghai, where on-site staff stated that mass production of the robot could begin by the end of 2026. Before that, it showed up at the Tesla Hollywood Diner opening in July 2025 and at a Miami showroom event in December 2025.
Tesla’s well-calculated display of Optimus gives the public a low-pressure first encounter with a robot that Tesla is preparing to soon deploy at scale. The company has previously indicated plans to manufacture Optimus robots at its Fremont facility at up to 1 million units annually, with an Optimus production line at Gigafactory Texas targeting 10 million units per year.
Tesla showcases Optimus humanoid robot at AWE 2026 in Shanghai
Musk has said that Optimus “has the potential to be more significant than the vehicle business over time,” and separately that roughly 80 percent of Tesla’s future value will come from the robot program. Whether that holds depends on production execution. For now, Boston gets a preview of what that future looks like, standing at the finish line on Boylston Street while 32,000 runners pass by.
Tesla Q1 Earnings: What Elon Musk and Co. will answer during the call
Elon Musk reveals shocking Tesla Optimus patent detail
